Intravenous nicorandil preserves endothelial junctions by decreasing endothelin-1 via activation of ATP-sensitive K+ channel

Vasa - Journal of Vascular Diseases

Volumn 36, Issue 3, 2007, Pages 175-179

  Zhao, J L ^a   Yang, Yue Jin ^a   Zhang, Y H ^a   Pei, W D ^a   Sun, Y H ^a   Zhai, M ^a   Gao, R L ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Acute myocardial infarction; Nicorandil; Reperfusion

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ENDOTHELIN 1; GLIBENCLAMIDE; NICORANDIL; VASCULAR ENDOTHELIAL CADHERIN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL JUNCTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY; DRUG ANTAGONISM; DRUG MECHANISM; ENDOTHELIUM; HEART MUSCLE REPERFUSION; NONHUMAN; SWINE;

ANIMALS; ANTIGENS, CD; CADHERINS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIN-1; GLYBURIDE; INJECTIONS, INTRAVENOUS; INTERCELLULAR JUNCTIONS; KATP CHANNELS; LIGATION; MYOCARDIAL INFARCTION; MYOCARDIUM; NICORANDIL; NO-REFLOW PHENOMENON; POTASSIUM CHANNEL BLOCKERS; RESEARCH DESIGN; SWINE; SWINE, MINIATURE; VASODILATOR AGENTS;

EID: 34548201761     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.36.3.175     Document Type: Article

References (19)

1. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
2. Chen XC, Zhang XM, Luo NS, Fang C, Liu YM, Wu W. Effects of endothelin receptor A antagonist FR139317 on rats with congestive heart failure. Acta Pharmacol Sin 2001; 22: 896-900.
3. Dejana E. Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 1996; 98: 1949-53.
4. Gavin JB, Thomson RW, Humphrey SM, et al. Changes in vascular morphology associated with the no-reflow phenomenon in ischemic myocardium. Virchows Arch 1983; 399: 325-32.
5. Galatius S, Wroblewski H, Sorensen VB. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation? Am Heart J 1999; 137(3): 549-54.
6. Harada K, Miwa A, Kaneta S, et al. Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats. Br J Pharmacol 1993; 109: 679-84.
7. Kelly RV, Cohen MG, Runge MS, et al. The no-reflow phenomenon in coronary arteries. J Thromb Haemostasis 2004; 2: 1903-7.
8. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54: 1496-1508.
9. Manciet LH, Poole DC McDonagh PF, et al. Microvascular compression during myocardial ischemia: mechanistic basis for no-reflow phenomenon. Am J Physiol 1994; 266: H1541-H50.
10. Niccoli G, Lanza GA, Shaw S, et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. Eur Heart J 2006; 27: 1793-8.
11. Reffelmann T, Kloner RA. The "no-reflow" phenomenon: basic science and clinical correlates Heart 2002; 87: 162-8.
12. Swinburn JM, Lahiri A, Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. J Am Coll Cardiol. 2001; 38: 19-25.
13. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 1989; 63: 18-24.
14. Wainstein MV, Goncalves SC, Zago AJ. Plasma endothelin-1 levels after coronary stenting in humans. Am J Cardiol 2003, 15; 92(10): 1211-4.
15. Wang Q-D, Hemsen A, Li X-S, et al. Local overflow and enhanced tissue content of endothelin followingmyocardial ischaemia and reperfusion in the pig: modulation by L-arginine. Cardiovasc Res 1995; 29: 44-9.
16. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 1991; 69: 370-7.
17. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765-72.
18. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-15.
19. Zhao JL, Yang YJ, Chen JL, et al. Nicorandil reduces myocardial no-reflow by protection of endothelial function via the activation of K(ATP) channel. Clin Chim Acta 2006; 374: 100-5.